Apomorphine-induced inhibition of striatal dopamine release: role of dopaminergic receptors in substantia nigra.
D008735:5-Methoxytryptamine / Q000378:metabolism; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D000242:Cyclic AMP / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D008297:Male; D009433:Neural Inhibition / Q000187:drug effects*; D009434:Neural Pathways / Q000502:physiology; D051381:Rats; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology*; D013378:Substantia Nigra / Q000187:drug effects / Q000502:physiology*; D005680:gamma-Aminobutyric Acid / Q000378:metabolism
D011954:Receptors, Dopamine; D008735:5-Methoxytryptamine; D005680:gamma-Aminobutyric Acid; D000242:Cyclic AMP; D001058:Apomorphine; D004298:Dopamine